Jaya Lakshmi Thangaraj

Author

Chonnam National University ORCID

Also Known As

Jaya L Thangaraj, Jaya Lakshmi Thangaraj, Jaya Thangaraj, JayaLakshmi Thangaraj, Thangaraj Jaya Lakshmi

Publications

189

Citations

H-Index

Concepts

All Affiliations

Chonnam National University Chonnam National University Hwasun Hospital Samsung Medical Center Chonnam National University Hospital Sungkyunkwan University

About

Jaya Lakshmi Thangaraj is an author at Chonnam National University specializing in immunology, cell biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	128
2	Cell Biology	3	3	128
3	Immunology	3	3	128
4	Autoimmunity	2	2	75
5	Cell Signaling	1	1	53

Jaya Lakshmi Thangaraj

Publications

179

Citations

H-Index

Page 1

	Year	Citations
Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells Jaya Lakshmi Thangaraj, Michael Coffey, Edith Lopez, Cell stem cell Effective KillingLiver PhysiologyImmunologyCell DeathLiver Cancer	2024	53
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model Jaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung‐Hoon Jung, Cellular and Molecular Immunology Cancer ImmunosurveillanceAntimyeloma EffectImmunologyMouse ModelImmune Checkpoint Inhibitor	2021	42
Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21 Jaya Lakshmi Thangaraj, Minh‐Trang Thi Phan, SoonHo Kweon, Cancer Immunology Immunotherapy Hematological MalignancyImmunologyK562 CellsAutoimmunityMultiple Myeloma Patients	2021	33
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model Jaya Lakshmi Thangaraj, Sung‐Hoon Jung, Manh-Cuong Vo, Cancer Immunology Immunotherapy	2022	21
Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma Tan-Huy Chu, Manh-Cuong Vo, Jaya Lakshmi Thangaraj, Translational Oncology	2022	19
Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model Thi-Anh-Thuy Tran, Young‐Hee Kim, Thi-Hoang-Oanh Duong, Frontiers in Immunology	2023	11

Page 1